Regardless of the propagation mechanism, extracellular tau concentrations increase as AD progresses, and concentrations of defined pTau epitopes in CSF can even be used to reliably diagnose disease severity [161,162,163]. The gene discussed is MAPT; the disease is Alzheimer disease.